The perioperative and long-term fates of patients with chronic limb-threatening ischaemia who underwent secondary major amputations.

chronic limb-threatening ischaemia endovascular therapy mortality secondary major amputation

Journal

International wound journal
ISSN: 1742-481X
Titre abrégé: Int Wound J
Pays: England
ID NLM: 101230907

Informations de publication

Date de publication:
Jan 2022
Historique:
revised: 11 03 2021
received: 21 01 2021
accepted: 15 03 2021
pubmed: 18 5 2021
medline: 22 12 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

This study investigated the perioperative and long-term fates of patients with chronic limb-threatening ischemia (CLTI) who underwent secondary major amputations. From April 2010 to December 2018, 1653 CLTI patients primarily underwent endovascular therapy (EVT). Of these patients, 138 who underwent secondary major amputations were included in this study. The primary outcome measure was the mortality. Prognostic factors associated with perioperative (30-day) and late mortality (after 30 days) were assessed. The 30-day mortality was 9.6%. Patients who died during the perioperative period had lower ejection fractions on echocardiography than those in the perioperative survivors (49.5 ± 14.9% vs 58.6 ± 12.4%, P = .018). None of the other clinical characteristics were significantly associated with perioperative death. Two-years postoperatively, 49.6%, 12.2%, and 4.3% of the patients had died, had contralateral amputations, and had additional above-knee amputations, respectively. In the alive patients who had not undergone additional amputation at 2 years, only 25.9% were ambulatory, whereas 51.7% and 22.4% were in wheelchairs and bedridden, respectively. An age ≥80 years and serum albumin <3.0 g/dL were significantly associated with late mortality (P = .032 and P = .042, respectively). In conclusion, the perioperative and long-term fates after secondary major amputation in CLTI patients who underwent EVT were considerably poor.

Identifiants

pubmed: 33998127
doi: 10.1111/iwj.13594
pmc: PMC8684859
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-43

Informations de copyright

© 2021 The Authors. International Wound Journal published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.

Références

Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75
pubmed: 17140820
Eur Heart J. 2018 Mar 1;39(9):763-816
pubmed: 28886620
J Vasc Surg. 2000 Jan;31(1 Pt 2):S1-S296
pubmed: 10666287
Circ J. 2018 Feb 23;82(3):847-856
pubmed: 29187666
Int Wound J. 2022 Jan;19(1):36-43
pubmed: 33998127
Eur J Vasc Endovasc Surg. 2016 Feb;51(2):248-57
pubmed: 26588994
Circ Cardiovasc Interv. 2013 Feb;6(1):68-76
pubmed: 23362307
Ann Vasc Surg. 2017 Jul;42:322-327
pubmed: 28389295
Circ Cardiovasc Interv. 2017 Dec;10(12):
pubmed: 29246911
J Am Coll Cardiol. 2016 Apr 26;67(16):1901-13
pubmed: 27012780
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33
pubmed: 31182334
Eur J Vasc Endovasc Surg. 2013 Jul;46(1):124-31
pubmed: 23628328
Circ Cardiovasc Interv. 2019 Dec;12(12):e008015
pubmed: 31771341

Auteurs

Tomoe Ogaki (T)

Department of Plastic Surgery, Kansai Rosai Hospital, Amagasaki, Japan.

Osamu Iida (O)

Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan.

Yosuke Hata (Y)

Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan.

Natsumi Yamauchi (N)

Department of Plastic Surgery, Kansai Rosai Hospital, Amagasaki, Japan.

Chika Yokoi (C)

Department of Plastic Surgery, Kansai Rosai Hospital, Amagasaki, Japan.

Mitsuyoshi Takahara (M)

Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Hiroto Terashi (H)

Department of Plastic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Toshiaki Mano (T)

Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan.

Yuji Asada (Y)

Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH